Connect Biopharma Holdings Ltd (CNTB)
1.72
-0.10
(-5.49%)
USD |
NASDAQ |
May 16, 16:00
1.76
+0.04
(+2.33%)
After-Hours: 20:00
Connect Biopharma Holdings Price to Book Value: 0.9598 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 15, 2024 | 0.9925 |
May 14, 2024 | 1.063 |
May 13, 2024 | 0.7907 |
May 10, 2024 | 0.818 |
May 09, 2024 | 0.7798 |
May 08, 2024 | 0.7907 |
May 07, 2024 | 0.8289 |
May 06, 2024 | 0.8562 |
May 03, 2024 | 0.8671 |
May 02, 2024 | 0.8453 |
May 01, 2024 | 0.7798 |
April 30, 2024 | 0.758 |
April 29, 2024 | 0.7471 |
April 26, 2024 | 0.7308 |
April 25, 2024 | 0.7417 |
April 24, 2024 | 0.7471 |
April 23, 2024 | 0.758 |
April 22, 2024 | 0.7362 |
April 19, 2024 | 0.8398 |
April 18, 2024 | 0.8289 |
April 17, 2024 | 0.8453 |
April 16, 2024 | 0.9434 |
April 15, 2024 | 0.9107 |
April 12, 2024 | 0.938 |
April 11, 2024 | 1.047 |
Date | Value |
---|---|
April 10, 2024 | 1.014 |
April 09, 2024 | 1.020 |
April 08, 2024 | 0.9816 |
April 05, 2024 | 1.167 |
April 04, 2024 | 0.9816 |
April 03, 2024 | 1.162 |
April 02, 2024 | 1.134 |
April 01, 2024 | 1.200 |
March 28, 2024 | 0.9489 |
March 27, 2024 | 0.878 |
March 26, 2024 | 0.7253 |
March 25, 2024 | 0.6926 |
March 22, 2024 | 0.698 |
March 21, 2024 | 0.6762 |
March 20, 2024 | 0.6817 |
March 19, 2024 | 0.6544 |
March 18, 2024 | 0.6762 |
March 15, 2024 | 0.7089 |
March 14, 2024 | 0.6108 |
March 13, 2024 | 0.6544 |
March 12, 2024 | 0.698 |
March 11, 2024 | 0.6326 |
March 08, 2024 | 0.6762 |
March 07, 2024 | 0.6545 |
March 06, 2024 | 0.7253 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1135
Minimum
May 09 2022
5.086
Maximum
Aug 10 2021
0.9234
Average
0.4383
Median
Oct 09 2023
Price to Book Value Benchmarks
Vanda Pharmaceuticals Inc | 0.597 |
Mirum Pharmaceuticals Inc | 4.978 |
89bio Inc | 1.729 |
Tharimmune Inc | 0.616 |
Lipella Pharmaceuticals Inc | 2.264 |
Price to Book Value Related Metrics
Price | 1.72 |
Earnings Yield | -61.36% |
Market Cap | 96.98M |